Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,121 | 31,062 | 31,060 | 33,623 | 37,976 |
| Marketable Securities | 92,241 | 57,682 | 44,096 | 32,542 | 14,798 |
| Receivables | 17,261 | 28,196 | 11,872 | 9,504 | 9,214 |
| Inventories | 4,876 | 4,576 | 3,828 | 3,089 | 2,888 |
| TOTAL | $150,823 | $124,185 | $93,942 | $81,285 | $66,675 |
| Non-Current Assets | |||||
| PPE Net | 577 | 518 | 553 | 499 | 302 |
| Investments And Advances | 15,010 | 15,281 | 1,508 | 1,494 | 4,493 |
| Other Non-Current Assets | 76,566 | 80,553 | 14,669 | 3,259 | 3,869 |
| TOTAL | $92,153 | $96,352 | $16,730 | $5,252 | $8,664 |
| Total Assets | $242,976 | $220,537 | $110,672 | $86,537 | $75,339 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 10,107 |
| Accounts payable and accrued liabilities | 7,850 | 8,579 | 6,226 | 2,082 | 4,253 |
| Accrued Expenses | 3,486 | 2,247 | 1,892 | 1,511 | 1,461 |
| TOTAL | $27,749 | $29,569 | $24,370 | $20,392 | $25,759 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $27,749 | $29,569 | $24,370 | $20,392 | $25,759 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 115,235 | 114,830 | 114,124 | 113,398 | 113,188 |
| Common Shares | 115 | 115 | 114 | 113 | 113 |
| Retained earnings | -175,687 | -193,146 | -291,476 | -305,233 | -317,880 |
| Other shareholders' equity | -152 | -75 | -14 | -17 | -12 |
| TOTAL | $215,227 | $190,968 | $86,302 | $66,145 | $49,580 |
| Total Liabilities And Equity | $242,976 | $220,537 | $110,672 | $86,537 | $75,339 |